Role of asymmetric dimethylarginine in the progression of carotid atherosclerosis in renal transplant patients

International Urology and Nephrology

Volumn 45, Issue 5, 2013, Pages 1463-1469

  Cobanoglu, Aysegul Kudu ^a   Gungor, Ozkan ^a   Kircelli, Fatih ^a   Altunel, Ekrem ^a   Asci, Gulay ^a   Ozbek, Sureyya Suha ^a   Toz, Huseyin ^a   Ok, Ercan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

ADMA; Carotid atherosclerosis; Renal transplantation

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTERY INTIMA PROLIFERATION; ARTICLE; B SCAN; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT FAILURE; HEPATITIS C VIRUS; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEINURIA; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; ARGININE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID INTIMA-MEDIA THICKNESS; DISEASE PROGRESSION; FEMALE; HEPACIVIRUS; HUMANS; KIDNEY TRANSPLANTATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; SERUM ALBUMIN; YOUNG ADULT;

EID: 84887075272     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0345-3     Document Type: Article

References (43)

1. Jardine AG, Gaston RS, Fellstrom BC, Holdaas H (2011) Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet 378:1419
2. Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17:1410
3. Simon A, Megnien JL, Chironi G (2010) The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 30:182
4. Töz H, Duman S, Altunel E et al (2004) Intima media thickness as a predictor of atherosclerosis in renal transplantation. Transplant Proc 36:156
5. Mackness MI, Durrington PN, Mackness B (2004) The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs 4:211
6. Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C (2009) Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 30:6
7. Zoccali C (2006). Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move. J Hypertens 24:611
8. Serg M, Kampus P, Kals J et al (2011) Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension. Blood Press 20:111
9. Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL (2011) Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci 342:135
10. Ok Sevinc E, Kircelli F, Asci G et al (2012) Neither oxidized nor anti-oxidized low-density lipoprotein level is associated with atherosclerosis or mortality in hemodialysis patients. Hemodialysis Int. doi: 10.1111/j.1542-4758
11. Fukumoto M, Shoji T, Emoto M, Kawagishi T, Okuno Y, Nishizawa Y (2000) Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol 20:703
12. Furuki K, Adachi H, Enomoto M et al (2008) Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima-media thickness progression: six-year prospective study using carotid ultrasonography. Hypertens Res 31:1185
13. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC (2011) Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease - a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 216:446-451
14. Mutluay R, Konca C, Erten Y et al (2010) Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients. Ren Fail 32:448
15. Kato A, Ishida J, Endo Y et al (2011) Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant 26:1967
16. Yu Z, Schneck M, Jacobs DR Jr et al (2011) Association of carotid intima-media thickness with progression of urine albumin-creatinine ratios in the multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis 57:62
17. Cofan F, Arias M, Nuñez I et al (2007) Impact of carotid atherosclerosis as assessed by B-mode ultrasonography on the evolution of kidney transplantation. Transplant Proc 39:2236-2238
18. Weingärtner O, Pinsdorf T, Rogacev KS et al (2010) The relationships of markers of cholesterol homeostasis with carotid intima-media thickness. PLoS ONE 5:13467
19. Stenvinkel P, Heimbürger O, Paultre F et al (1999) Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999(55):1899
20. Pyke KE, Tschakovsky ME (2005) The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 568:357
21. Maas R, Xanthakis V, Polak JF et al (2009) Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke 40:2715
22. Furuki K, Adachi H, Matsuoka H et al (2007) Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study. Atherosclerosis 191:206
23. De Gennaro ColonnaV, Bianchi M, Pascale V et al (2009) Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. Med Sci Monit 15:91
24. Bai Y, Sun L, Du L, Zhang T, Xin W, Lan X, Du G (2012). Association of circulating levels of asymmetric dimethylarginine (ADMA) with carotid intima-media thickness: Evidence from 6168 participants. Ageing Res Rev. 2012 Feb 14
25. Kanazawa I, Yano S, Notsu Y, Yamaguchi T, Nabika T, Sugimoto T (2011). Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus. Clin Endocrinol (Oxf) 74:467
26. Kumagai H, Sakurai M, Takita T et al (2006) Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients. Am J Kidney Dis 48:797
27. Zhang W, Zhou C, Xie J, Chen B, Chang L (2009) Serum asymmetric dimethylarginine and endothelial function after renal transplantation. Zhong Nan Da Xue Xue Bao Yi Xue Ban 34:289
28. Yilmaz MI, Saglam M, Caglar K et al (2005) Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 80:1660
29. Abedini S, Meinitzer A, Holme I et al (2010) Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int 77:44
30. Esposito C, Grosjean F, Torreggiani M et al (2009) Increased asymmetric dimethylarginine serum levels are associated with acute rejection in kidney transplant recipients. Transplant Proc 41:1570
31. Baid S, Pascual M, Williams WW Jr et al (1999) Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 10:146
32. Sawayama Y, Okada K, Maeda S, Ohnishi H, Furusyo N, Hayashi J (2006) Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy. Fukuoka Igaku Zasshi 97:245
33. Völzke H, Schwahn C, Wolff B et al (2004) Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 174:99
34. Caliskan Y, Oflaz H, Pusuroglu H et al (2009) Hepatitis C virus infection in hemodialysis patients is not associated with insulin resistance, inflammation and atherosclerosis. Clin Nephrol 71:147
35. Demirci MS, Toz H, Yilmaz F et al (2010) Risk factors and consequences of post-transplant diabetes mellitus. Clin Transplant 24:170
36. Holvoet P, Jenny NS, Schreiner PJ, Tracy RP, Jacobs DR, Multi-Ethnic Study of Atherosclerosis (2007) The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 194:245
37. Hoogeveen RC, Ballantyne CM, Bang H et al (2007) Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Diabetologia 50:36
38. Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G (1994) The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients. Kidney Int 46:869
39. Shoji T, Fukumoto M, Kimoto E et al (2002) Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease. Kidney Int 62:2230
40. van Tits LJ, Smilde TJ, van Wissen S, de Graaf J, Kastelein JJ, Stalenhoef AF (2004) Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia. J Investig Med 52:177
41. Uusitupa MI, Niskanen L, Luoma J et al (1996) Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16:1236
42. Balci M, Kirkpantur A, Gulbay M, Gurbuz OA (2010) Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Hemodial Int 14:425
43. Ari E, Kaya Y, Demir H et al (2011) Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients. Hemodial Int 15:453-459